B

Cencora, Inc. COR

$323.67 -$2.57-0.79% NYSE
Recommendation
Dividend Power Score
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
52-Week Range
P/E (TTM)
EPS (TTM)
Access our Premium Ratings
Get Access

Rating

Reward
Risk

Rating Factors

Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Yield Index

Company Overview

Cencora, Inc. is a global pharmaceutical solutions organization that operates primarily within the healthcare distribution and services industry. Formerly known as AmerisourceBergen, the company rebranded to Cencora in 2023 to reflect its broader role beyond traditional drug distribution. Its core business centers on the distribution of pharmaceuticals, biotechnology products, and healthcare services to a wide range of providers, manufacturers, and patients.

The company’s primary revenue driver is pharmaceutical distribution, particularly in the U.S. healthcare market, where it serves retail pharmacies, hospital systems, physician practices, and long-term care facilities. Cencora is strategically positioned as one of the largest pharmaceutical distributors in North America, with scale, regulatory expertise, and supply chain infrastructure serving as key competitive advantages. Founded in 2001 through the merger of Bergen Brunswig and AmeriSource Health, the company expanded organically and through acquisitions, becoming a critical intermediary in the global pharmaceutical supply chain.

Data compiled by narrative technology. May contain errors.
Sector

Income Statement

Total Revenue (TTM)
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)

Balance Sheet

Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)

Cash Flow

Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)

Filings

Filing Date
Wednesday, August 5, 2026
Period Date
Tuesday, June 30, 2026
Next Filing
Week of Nov 23 and 27 (est)

Price History

Loading...
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
52-week Low
52-week High

Valuation

Market Cap
Enterprise Value
Price/Sales (TTM)
Price/Book (Q)

Dividends and Shares

Shares Outstanding
Dividend Per Share (Most Recent)
Dividend Per Share (TTM)

Corporate Info

Phone Number
610 727 7000
Address
1 West First Avenue
Conshohocken, PA 19428-1800
Country
Year Founded

Headlines

9/10/2026 - Zacks Investment Research